Cargando…

Risk factors for SARS-CoV-2 infection and course of COVID-19 disease in patients with IBD in the Veterans Affair Healthcare System

OBJECTIVE: Our aim was to explore the risk of infection with all classes of inflammatory bowel disease (IBD) medications and the impact of these medications on the disease course in a nationwide cohort of patients with IBD. DESIGN: This was a retrospective national cohort study of patients with IBD...

Descripción completa

Detalles Bibliográficos
Autores principales:	Khan, Nabeel, Mahmud, Nadim, Trivedi, Chinmay, Reinisch, Walter, Lewis, James D
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BMJ Publishing Group 2021
Materias:	Covid-19
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7985980/ https://www.ncbi.nlm.nih.gov/pubmed/33753416 http://dx.doi.org/10.1136/gutjnl-2021-324356

Ejemplares similares

Short-term Effects of Canceled Elective Procedures Due to COVID-19: Evidence From the Veterans Affairs Healthcare System
por: Tran, Linda Diem, et al.
Publicado: (2021)

Mortality Among Veterans’ Affairs Community Living Center (CLC) Residents with COVID-19
por: Bej, Taissa, et al.
Publicado: (2021)

Effectiveness of SARS-CoV-2 Vaccination in a Veterans Affairs Cohort of Patients With Inflammatory Bowel Disease With Diverse Exposure to Immunosuppressive Medications
por: Khan, Nabeel, et al.
Publicado: (2021)

Absence of racial and ethnic disparities in COVID-19 survival among residents of US Veterans’ Affairs community living centers
por: Alabdely, Mayyadah, et al.
Publicado: (2022)

COVID-19 Vaccine Effectiveness Against the Omicron Variant in a Veterans Affairs Cohort of Patients With Inflammatory Bowel Disease
por: Khan, Nabeel, et al.
Publicado: (2023)

Incidence of Long COVID and Impact of Medications on the Risk of Developing Long COVID in a Nationwide Cohort of IBD Patients
por: Khan, Nabeel, et al.
Publicado: (2023)

Correction: Risk factors for SARS-CoV-2 infection and course of COVID-19 disease in patients with IBD in the Veterans Affair Healthcare System
Publicado: (2021)

Prevalence of SARS-CoV-2 Antibody in Healthcare Workers in Central Pennsylvania
por: Kwon, Taesung, et al.
Publicado: (2021)

Genomic investigation to identify the source of SARS-CoV-2 infection among healthcare personnel
por: Sansom, Sarah, et al.
Publicado: (2022)

SARS-CoV-2 transmission by asymptomatic healthcare workers positive to screening swab: an Italian study
por: Palese, Francesca, et al.
Publicado: (2022)

Favourable course in a cohort of Parkinson’s disease patients infected by SARS-CoV-2: a single-centre experience
por: Buccafusca, Maria, et al.
Publicado: (2021)

SARS-CoV-2 N95 contamination worn under a face shield, via medical mask surrogate, in healthcare providers treating COVID-19
por: Graves, Amanda, et al.
Publicado: (2022)

Liver function test abnormalities at hospital admission are associated with severe course of SARS-CoV-2 infection: a prospective cohort study
por: Weber, Sabine, et al.
Publicado: (2021)

Comparison of the course of SARS-CoV-2 infection in left ventricular assist device recipients implanted before and during COVID-19 pandemic
por: Wiśniowska-Śmiałek, Sylwia, et al.
Publicado: (2023)

Prevalence and risk factors of SARS-CoV-2 antibody responses among healthcare workers (June 2020–November 2021)
por: Barrufet, Maria Pilar, et al.
Publicado: (2023)

Adverse Events Related to SARS-CoV-2 Vaccine in a Nationwide Cohort of Patients With Inflammatory Bowel Disease
por: Mahmud, Nadim, et al.
Publicado: (2022)

The Impact of Coronavirus Disease 2019 (COVID-19) Pandemic on Device-Associated Healthcare-Associated Infection
por: Kang, Minji, et al.
Publicado: (2021)

Air filtration and SARS-CoV-2
por: Nazarenko, Yevgen
Publicado: (2020)

Neurological Complications of SARS-CoV, MERS-CoV, and COVID-19
por: Alshebri, Munirah Saad, et al.
Publicado: (2020)

Antidiabetes Agents against Sars-Cov-2 Infection
por: Vitiello, Antonio, et al.
Publicado: (2020)

Re-reading the SARS-COV-2 Epidemic in Bergamo
por: Schena, Daniele, et al.
Publicado: (2020)

Infections sévères à SARS-CoV-2
por: Taghboulit, N., et al.
Publicado: (2021)

Association between stopping universal SARS-CoV-2 admission testing and hospital-onset SARS-CoV-2 in England and Scotland
por: Pak, Theodore, et al.
Publicado: (2023)

COVID-19 Infection in the Veterans Health Administration: Gender-specific Racial and Ethnic Differences
por: Upchurch, Dawn M., et al.
Publicado: (2022)

The OM-85 bacterial lysate inhibits SARS-CoV-2 infection of epithelial cells by downregulating SARS-CoV-2 receptor expression
por: Pivniouk, Vadim, et al.
Publicado: (2022)

The SARS-CoV-2 Outbreak: an Epidemiological and Clinical Perspective
por: Wong, Rebecca S. Y.
Publicado: (2020)

Diaphragmatic myoclonus due to SARS-CoV-2 infection
por: Borroni, Barbara, et al.
Publicado: (2020)

SARS-CoV-2, an Underestimated Pathogen of the Nervous System
por: Jakhmola, Shweta, et al.
Publicado: (2020)

Nutritional status in post SARS-Cov2 rehabilitation patients
por: Gobbi, M., et al.
Publicado: (2022)

Dysphagia and mechanical ventilation in SARS-COV-2 pneumonia: It's real
por: Bordejé Laguna, Luisa, et al.
Publicado: (2022)

SARS-CoV-2 vaccine-related neurological complications
por: Oonk, Nicol G. M., et al.
Publicado: (2022)

A Cluster of Aspergillosis Associated with SARS-CoV-2
por: VerLee, Kerrie, et al.
Publicado: (2021)

Mitigation Strategies to Reduce Aerosolization of SARS-CoV-2
Publicado: (2022)

Comparative effectiveness of different primary vaccination courses on mRNA-based booster vaccines against SARs-COV-2 infections: a time-varying cohort analysis using trial emulation in the Virus Watch community cohort
por: Nguyen, Vincent Grigori, et al.
Publicado: (2023)

The Evidence for High-Titer Convalescent Plasma in SARS-CoV-2
por: Fisher, David L., et al.
Publicado: (2021)

Nationwide seroprevalence of antibodies against SARS-CoV-2 in Israel
por: Reicher, Shay, et al.
Publicado: (2021)

Broken Heart (Takotsubo) Syndrome Triggered by SARS-CoV-2
por: Finsterer, Josef
Publicado: (2021)

Asthma and viruses: A focus on rhinoviruses and SARS-CoV-2
por: Padayachee, Yorissa, et al.
Publicado: (2021)

Thoracic sarcopenia as a predictive factor of SARS-COV2 evolution
por: Koehler, J., et al.
Publicado: (2022)

Seroepidemiology of SARS-CoV-2, Yamagata, Japan, June 2020
por: Morikane, Keita, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_8j27n5f11vff1gc546pvhc6cbu